/ CompletedNot Applicable Long term observational study on efficiency of a TNF-alpha blocker therapy on nail psoriasis in patients with moderate to severe plaque psoriasis or psoriatic arthritis - NAPSI
/ Not yet recruitingNot Applicable A Multi-center, Randomized, Vehicle-Controlled Study to Assess the Efficacy and Safety of Adalimumab in Combination with Topical Treatment (Calcipotriol/Betamethasone) in Subjects with Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE) - BELIEVE
/ Not yet recruitingNot Applicable A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral experienced, HIV-1 Infected Subjects
100 Clinical Results associated with Abbott GmbH (Germany)
0 Patents (Medical) associated with Abbott GmbH (Germany)
100 Deals associated with Abbott GmbH (Germany)
100 Translational Medicine associated with Abbott GmbH (Germany)